Greyhound racing industry defends sport as Wales weighs ban
Greyhound Racing Industry Defends Sport as Wales Weighs Ban The greyhound racing industry is pushing back against plans to ban the sport in Wales, citing data that shows a significant redu…
Fujitsu, Logistics Knight Japan, and Isuzu Motors launch joint pilot project to build pharmaceutical logistics platform aiming for stable supply
Fujitsu, Logistics Knight Japan, and Isuzu Motors Launch Joint Pilot Project Fujitsu Limited, Logistics Knight Japan Co., Ltd. (LKJ), and …
30 journalists embody struggle for freely reported environmental coverage
Journalists' Struggle for Environmental Coverage Thirty journalists embody the struggle for freely reported environmental coverage, facing…
What are possibilities for early diagnosis of head and neck squamous cell carcinoma?
Early Diagnosis of Head and Neck Squamous Cell Carcinoma Head and neck squamous cell carcinoma (HNSCC) is a diverse group of cancers origi…
RTL AdAlliance adds ORF to European sales network
RTL AdAlliance Partners with ORF to Expand International Sales RTL AdAlliance and ORF-Enterprise have formed an exclusive strategic partne…
Nanoform Finland Oyj: Nanoform Partners With Revio Therapeutics To Develop Long-Acting Locally-Delivered Hydrogel Nanoformulation To Treat Glioma
Nanoform Partners with Revio Therapeutics Nanoform Finland Plc announced a partnership with Revio Therapeutics to co-develop and commercia…
Fibre Frolic keeps hundreds of people in stitches
Fibre Frolic Keeps Hundreds in Stitches The Vankleek Hill Fibre Frolic is a colourful event with 21 vendor booths offering yarns, garment …
Army Abducts Two Palestinians In Bethlehem And Nablus
Army Abducts Two Palestinians In Bethlehem And Nablus Israeli soldiers abducted two Palestinians in Bethlehem and Nablus, in the occupied …
Cullinan Therapeutics, Inc.: Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
Cullinan Therapeutics Shares Preclinical Data for CLN-978 Cullinan Therapeutics, Inc. (Nasdaq: CGEM) presented new preclinical data for CL…